59.70USD-2.34%Mkt Cap: 5.29B USDP/E: 349.88Last update: 2026-06-01
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPI…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap5.29B USD
Enterprise Value5.46B USD
Revenue (TTM)288.06M USD
Gross Profit145.08M USD
Net Income (TTM)-68.92M USD
Revenue/Share3.320 USD
Last Price59.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees216
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)349.88
P/E (Forward)11.10
PEG—
EV/EBITDA117.17
EV/Revenue18.96
P/S19.10
P/B50.29
EPS (TTM)0.17
EPS (Forward)5.57
52W Range
11.8593% of range63.45
52W High63.45 USD
52W Low11.85 USD
Profitability
Gross Margin91.64%
Oper. Margin46.29%
EBITDA Margin16.19%
Profit Margin-43.53%
ROE-154.03%
ROA-21.02%
Growth
Revenue Growth4158.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-35.69M USD
CapEx (TTM)6.34M USD
FCF Margin3.33%
FCF Yield0.18%
Net Debt-37.96M USD
Net Debt/EBITDA-0.81
Balance Sheet
Debt/Equity4.42
Current Ratio2.22
Quick Ratio1.98
Book Value/Sh1.230 USD
Cash/Share2.505 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)65.13 USD
Target Range59.00 USD – 70.00 USD
# Analysts8
Ownership
Shares Out.88.93M
Float62.54M
Insiders12.69%
Institutions70.12%
Short Interest
Short Ratio6.6d
Short % Float14.26%
Short % Out.11.48%
Shares Short10.21M
Short (prev mo.)11.42M
Technical
SMA 5043.58 (+37.0%)
SMA 20034.06 (+75.3%)
Beta0.42
S&P 52W Chg27.94%
Avg Vol (30d)1.38M
Avg Vol (10d)1.41M
Technical Indicators
RSI (14)73.0
MACD5.7736
MACD Signal5.5146
MACD Hist.+0.2590
BB Upper72.04 USD
BB Middle53.71 USD
BB Lower35.39 USD
BB Width68.23%
ATR (14)2.842 USD
Vol Ratio (20d)0.33x